June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Rate of visual field progression in normal tension glaucoma patients
Author Affiliations & Notes
  • Yeon Ggoch Park
    Ewha Womans University, Mokdong Hospital, Seoul, Korea (the Republic of)
  • Ji Won Kim
    Ewha Womans University, Mokdong Hospital, Seoul, Korea (the Republic of)
  • Kyu-Ryong Choi
    Ewha Womans University, Mokdong Hospital, Seoul, Korea (the Republic of)
  • Footnotes
    Commercial Relationships Yeon Ggoch Park, None; Ji Won Kim, None; Kyu-Ryong Choi, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 1054. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yeon Ggoch Park, Ji Won Kim, Kyu-Ryong Choi; Rate of visual field progression in normal tension glaucoma patients. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):1054.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To investigate the rate of visual field progression in patients with normal tension glaucoma (NTG) and analysis the clinical characteristics between progressing and non-progressing group.

Methods: Records with five or more visual field tests of 265 eyes (265 patients) which had been diagnosed with NTG at Ewha Womans University, Mokdong hospital was reviewed. Patients were classified into progressing and non-progressing groups by visual field trend analysis. Kaplan - Meier survival curves was used to estimate five year progression rate.

Results: Among 256 eyes with medically treated NTG, 59 eyes (22.3%) were classified into the progressing group. The mean baseline IOP was higher in the progressing group (p=0.027) and mean baseline MD were different between progressing and non-progressing group (-3.91±2.95dB vs -2.67±2.81dB, p=0.042). The 5 years progressing rate of medically treated NTG was 16% and 5 years progressing rate of under age 40 was 12% and over age 40 was 16%. And 5 years progressing rate of mono-therapy group was 15% and double-therapy group was 21%.

Conclusions: After 5 years, 16% of medically treated NTG showed a confirmed localized VF progression. Special attention and proper treatment should be given to patients with high baseline IOP or worse baseline MD in visual field test.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×